APRE · Aprea Therapeutics, Inc.
Market Cap
$10.07M
Shares
12.59M
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-02-26 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2025-09-09 | H.C. Wainwright Global Investment Conference | Conference |
| 2024-10-01 | Lytham Partners Fall 2024 Investor Conference | Conference |
| 2024-09-19 | Life Sciences Investor Forum | Event |
| 2024-09-10 | H.C. Wainwright 26th Annual Global Investment Conference | Conference |
| 2024-06-24 | -- Virtual KOL Event on APR-1051, a Highly Selective and Potentially Best-in-Class Oral WEE1 Inhibitor | Event |
| 2023-10-31 | Aprea Therapeutics KOL Event | Event |
| 2023-09-11 | HC Wainwright 25th Annual Global Investment Conference | Conference |
| 2023-06-21 | Maxim Virtual Healthcare Conference | Conference |
| 2023-03-14 | Oppenheimer 33rd Annual Healthcare Conference | Conference |
Source: https://ir.aprea.com/
Key facts
CIK
1781983
CUSIP
03836J201
13F (30d)
28 filings
28 filers
Visit website
Investor relations